Publication:
Serum and Urine Galectin-9, IP-10 and SIGLEC-1 as Biomarkers of Disease Activity in Patients with Systemic Lupus Erythematosus

Simple item page
dc.contributor.authorMirioğlu, Şafak
dc.contributor.authorÇınar, Suzan
dc.contributor.authorUludağ, Ömer
dc.contributor.authorGürel, Erdem
dc.contributor.authorVarelci, Sibel
dc.contributor.authorÖzlük, Mesude Yasemin
dc.contributor.authorKılıçaslan, Işın
dc.contributor.authorYalçınkaya, Yasemin
dc.contributor.authorYazıcı, Halil
dc.contributor.authorGül, Ahmet
dc.contributor.authorİnanç, Murat
dc.contributor.authorArtım Esen, Bahar
dc.contributor.institutionauthorMİRİOĞLU, ŞAFAK
dc.date.accessioned2021-11-12T20:59:07Z
dc.date.available2021-11-12T20:59:07Z
dc.date.issued2021-11-06T00:00:00Z
dc.identifier.urihttp://hdl.handle.net/20.500.12645/29631
dc.subjectMirioğlu Ş., Çınar S., Uludağ Ö., Gürel E., Varelci S., Özlük M. Y. , Kılıçaslan I., Yalçınkaya Y., Yazıcı H., Gül A., et al., -Serum and Urine Galectin-9, IP-10 and SIGLEC-1 as Biomarkers of Disease Activity in Patients with Systemic Lupus Erythematosus-, ACR Convergence 2021, District Of Columbia, Amerika Birleşik Devletleri, 5 - 09 Kasım 2021, cilt.73, ss.687-689
dc.titleSerum and Urine Galectin-9, IP-10 and SIGLEC-1 as Biomarkers of Disease Activity in Patients with Systemic Lupus Erythematosus
dc.typeConference Paper
dspace.entity.typePublication
local.avesis.id0173fbc9-7ad2-4be6-9829-63b066bcfc7f
local.publication.isinternational1
relation.isAuthorOfPublication1a6fde04-64ba-4074-8a18-b696ffbbbd3e
relation.isAuthorOfPublication.latestForDiscovery1a6fde04-64ba-4074-8a18-b696ffbbbd3e

Files

Collections

Yayınlar - Eserler